Lyon, France
At the intersection between computer science and biomedicine, NOVADISCOVERY has developed an innovative approach which de-risks decision-making across the entire drug development lifecycle: research, clinical studies and market.
Based in Lyon, France, NOVADISCOVERY brings together a multidisciplinary team of experts (from biology and mathematics to computer science) dedicated to shifting away from the prevailing model, which relies heavily on serendipity and costly trial-and-error, in favor of one driven by mathematics, predictive analytics and computer science.